Phil Mallinder

Phil started his career at AZ R&D Charnwood in Loughborough, working there for 17 years, initially as a discovery lab scientist, then managing a team of molecular biologists and ultimately becoming a project leader for both large molecule and small molecule projects generating several candidate drugs. Phil spent 2 years at PRECOS a pre-clinical oncology CRO before moving to Novartis as an early development Global Project Manager. Phil returned to AZ/Medimmune in 2014 and has spent the past 8 years as a project manager on a range of early oncology drug development projects. He was appointed as a team leader within Early Oncology Project Management when Global Portfolio and Project Management was formed within AstraZeneca in 2019 and has managed a team of up to 10 early oncology Global Project Managers advancing projects in the AZ early pipeline. Recently Phil has been appointed Head of Early Oncology Project Management and has oversight over all the ~30 Global Project Managers who manage ~50 early oncology projects from pre-candidate Drug investment decision to Phase 3 transition.